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Abstract
OBJECTIVE: The purpose of this study was to assess the technical feasibility of a fetal trans-apical stent delivery into the pulmonary
artery using a novel hybrid-intervention technique as a possible route for prenatal minimally invasive heart-valve-implantation
approaches.
METHODS: Pregnant Pre-Alp sheep between 122 and 128 days’ gestation (n = 3) underwent a midline laparotomy. The fetus was left in
utero or partially externalized and its chest was opened via a left-sided minithoracotomy. The fetal heart was cannulated and a guide
wire was introduced through the ductus arteriosus into the aorta. A 14-French delivery system was then mounted onto the guide wire
and advanced to the landing zone in the pulmonary artery, where the stent was deployed. The position of the stent was conﬁrmed
using echocardiography, angiography as well as computed tomography.
RESULTS: The trans-apical implantation was successful in all animals. However, at necropsy in one animal, the stent was found to partly
occlude one of the pulmonary valvular leaﬂets. Bleeding at the antero-apical incision occurred in all animals but could be managed
without fetal demise. No fetal cardiopulmonary bypass was performed. In all animals, contrast angiography displayed normal perfusion
of the pulmonary vasculature as well as the ductus arteriosus.
CONCLUSIONS: Our study demonstrates the principal technical feasibility of a prenatal stent delivery into the pulmonary artery using a
novel trans-apical hybrid-intervention technique. This approach demonstrates the ﬁrst step towards possible future minimally invasive
prenatal heart-valve-implantation procedures.
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INTRODUCTION
Based on advanced fetal-imaging techniques, there is an increas-
ing interest in performing prenatal cardiac interventions, in
particular in severe anatomic cardiac obstructions, such as pul-
monary or aortic-valve stenosis [1–5]. Both lesions can induce ir-
reversible ventricular malformation and dysfunction as well as
hypoplasia of the adjacent great arteries, leading to severe
cardiac malformation and decompensation [1,4]. The resulting
insufﬁcient growth of the ventricle has a substantial impact on
postnatal treatment options, as in most cases only palliative
surgical procedures may be offered and common treatment
options might be limited, that is, univentricular strategies [1,5,6].
Moreover, heart failure may develop during late gestation,
leading to either fetal loss or delivery of a premature infant who
requires urgent interventions [5,6].
The reduction of intrauterine progression of fetal cardiac mal-
formations is desirable to minimize consecutive congenital mal-
development of cardiovascular structures. Therefore, the relief of
obstructive malformations, such as heart-valve stenoses, using
interventional procedures has been suggested to promote func-
tional recovery of the affected ventricle [4,6,7]. The principal
feasibility of fetal cardiac interventions has been proven in both,
in selected human fetuses 4] as well as in various experimental
animal models involving minimally invasive fetoscopic- as well
as catheter-based approaches [2,3,8,9]. In humans, successful
fetal cardiac catheterization and balloon valvuloplasty by
ultrasound-guided direct puncture of the obstructed ventricle
have been reported by several groups [1,4,7,10–13]. Although en-
couraging, these indirect percutaneous interventions were asso-
ciated with a high risk for major complications including1These authors contributed equally to the article.
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pericardial tamponade, hematothorax, cardiac arrhythmia, pre-
natal birth, and even fetal death [1,5,14,16]. Furthermore, reste-
noses of the obstructed segments have been repeatedly
reported after prenatal cardiac-balloon interventions [4,14].
The implantation of a stented heart valve into the orthotopic
valvular position, as currently performed in elderly patients [15],
could potentially overcome these limitations by dilating the ob-
structive segment, restoring normal valvular functionality as well
as preventing valvular restenosis. While the reported balloon-
dilation approaches often aimed at a bridging of affected fetuses
until birth, prenatal heart-valve implantations could allow for a
more ﬂexible follow-up period by fully restoring native valvular
functionality. Besides that, an open-chest closed-heart in utero
intervention technique could combine optimal control of peri-
as well as acute postoperative bleeding complications with a
minimally invasive catheter-based intervention.
The purpose of this acute study in fetal sheep was to assess
the technical feasibility of a minimally invasive trans-apical stent
implantation into a deﬁned landing zone of the pulmonary
artery (PA) using a novel fetal hybrid-intervention technique.
This approach could serve as a potential future route for minim-
ally invasive prenatal heart-valve implantation procedures.
MATERIALS AND METHODS
Experimental protocol
We studied three pregnant Pre-Alp sheep between 122 and 128
days’ gestation (term 145 days, mean weight 1500 g). All animals
received humane care in compliance with the Principles of
Laboratory Animal Care as well as with the ‘Guide for the Care
and Use of Laboratory Animals’ published by the National
Institutes of Health (NIH publication no. 85-23, revised 1985).
After overnight fasting, each animal was sedated by intravenous
injection of pentothal (10 mg kg−1 body weight). The sheep
were placed in supine position, intubated, ventilated with 100%
oxygen and 1–2% isoﬂurane, and monitored continuously
throughout the entire procedure. Fetuses were heparinized prior
to stent deployment (0.5 mg heparin i.a. per fetus, Heparine
Choay®, Sanoﬁ Synthelabo). No anti-arrhythmic agents were
used during or after the procedure. All procedures were
approved by the Institutional Ethics Committee (10-16QRF30A).
Imaging modalities
Prior to implantation, major cardiac structures and thoracic
vessels were located with transuterine ultrasound equipment
(Philips Healthcare iE33® xMATRIX Ultrasound System; the
Netherlands) with sterile packed 3–5-MHz broadband transdu-
cers. PA and pulmonary valve annulus (PVA) diameters were
determined: PA diameter 10.0 ± 0.1 mm; and PVA diameter
9.78 ± 0.5 mm. Intra- and postoperative imaging included con-
trast angiography (OEC® 9900 Elite General Electric, Fairﬁeld, CT,
USA; intraventricular contrast injection) as well as computed tom-
ography (CT, Siemens, Munich, Germany). Three-dimensional CT
reconstruction and volume rendering were performed using the
OsiriX Image Processing Software (OsiriX Mac OS X; Version
3.8.1).
Operative technique
After transuterine sonographic assessment, the uterus was exter-
iorized through a maternal midline laparotomy and the fetal
heart was approached using two different routes: (1) the fetus
was left in utero and, after thoracotomy, its skin was sutured to
the uterine wall or (2) it was partially externalized from the
uterus and thoracotomy was performed – the upper part of the
body remained within the maternal uterine cavity. The amniotic
ﬂuid (415 ± 334 ml) was collected and stored. The fetal chest
was opened via a left-sided 4th intercostal space minithoracot-
omy. Following pericardiotomy and optimal cardiac exposure, a
5/0 pledged purse-string suture was placed on the right
antero-apical region (TI-CRON® 5/0, Syneture Suture, IPP
Pharma, France). Next, the fetal heart was cannulated to perform
pressure measurements as well as contrast angiography prior to
deployment. Thereafter, a 16-gauge catheter was inserted into
the apex of the right ventricle and a 0.35-mm guide wire was
introduced into the catheter and through the ductus arteriosus
into the aorta (see Fig. 1 for detailed anatomy). The 14 French
delivery system (Zenith Flex® Catheter, Cook Medical,
Bloomington, IN, USA) was then mounted onto the guide wire
and advanced to the landing zone. We aimed to deploy the
stent (1.0/1.2 × 1.0 cm; self-expanding nitinol stent,
Sinus-Repo-Visual-6F, OptiMed, Ettlingen, Germany) supravalvu-
lar into the PA of the fetus. After delivery, the position of the
stent was conﬁrmed using echocardiography as well as angiog-
raphy. At the end of the procedure, the delivery system was
removed and the right-ventricular implantation site was closed
with the 5/0 pledged pre-placed purse-string suture (four to ﬁve
pledges; TI-CRON® 5-0, Syneture Suture, IPP Pharma, France). At
post-mortem examination, the stent position in the PA as well as
the artery wall integrity was assessed macroscopically and com-
pared to in vivo ﬁndings.
Disclosures and freedom of investigation
The equipment and technology used in the study were pur-
chased using academic funds. The authors had full control of the
Figure 1: Fetal cardiac anatomy. Post-mortem angiography through umbilical
vein including descending aorta (‡) and the ductus arteriosus at its entry into
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design of the study, methods used, analysis of data, and produc-
tion of the written report.
Statistical analysis
Quantitative data are presented as mean ± standard deviation




After mounting onto the guide wire, the delivery system was
introduced into the ventricle via the antero-apical incision
(Fig. 2 ; Suppl. Video 1) and advanced to the deﬁned landing
zone located 3.0–5.0 mm distal to the PVA (Fig. 3). The stent de-
ployment was successful in all three animals, and all fetuses sur-
vived the surgical procedure of approximately 60 min, lasting
from maternal laparotomy to the end of post-deployment in
vivo evaluation. The mean distance from the ventricle entry
point to the proximal stent margin after delivery was
19.7 ± 0.6 mm (Fig. 4). However, the introduction of the delivery
device into the right ventricle was difﬁcult in all fetuses, and sig-
niﬁcant blood loss occurred in one of the animals. No fetal
cardiac arrhythmia or bradycardia was observed during the pro-
cedures, and no fetal cardiac bypass was used.
Stent deployment and positioning
The stent position and the perfusion of the adjacent vessels was
veriﬁed using Doppler sonography as well as contrast angiog-
raphy (Fig. 5). In one of the fetuses (F1), the stent was deployed
supravalvular into the PA, and initial sonographic assessment
indicated a stent position clearly proximal to the ductus arterio-
sus Botalli (DAB). However, at angiography the distal stent
ending was found to reach into the proximal part of the DAB.
Although still located within the predeﬁned lading zone, this
indicated a slight stent migration after deployment (Fig. 5). As
conﬁrmed by Doppler sonography and angiography, this migra-
tion did not result in an impairment of DAB or PA perfusion in
this fetus (Suppl. Video 2, Fig. 5). In another fetus (F2), echocar-
diography revealed that one of the pulmonary valvular leaﬂets
could not be fully identiﬁed, suggesting some impairment of the
cusp by the proximal stents’ struts. In the third fetus (F3), no
signs of migration or pulmonary cusp impairment could
observed in vivo, indicating optimal positioning. In all fetuses
(F1–3), contrast angiography as well as transepicardial echocardi-
ography displayed normal perfusion of the pulmonary vascula-
ture as well as of the DAB (Fig. 5).
Figure 2: The fetal open-chest in utero trans-apical hybrid technique. After exteriorization of the uterus (A), a small incision was made in the uterine wall (B, *A–C:
uterus), and the fetal chest was opened (C). The 16-gauge catheter was inserted into the apex of the right ventricle (F) and the delivery system is advanced to the
landing zone. The stent is then deployed supravalvular into the distal portion of the pulmonary artery (D–F).
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Post-mortem examination
After in vivo assessment, fetuses were harvested and examined
with regard to stent position, native leaﬂet impairment, or further
procedural complications. In all fetuses, post-mortem analysis
revealed strut impregnations on the wall of the PA but lacking any
laceration or perforation of the vessel wall (Fig. 4). In one fetus
(F2), the intra-operative sonographic ﬁnding of a too-proximal
stent positioning could be conﬁrmed, as one of the native pul-
monary leaﬂets was partly impaired by one of the proximal stent
strut endings. In addition, in fetus F1, the angiographic stent pos-
ition could be conﬁrmed with the distal stent ending reaching
into the proximal DAB. In fetus F3, the stent was situated in the
distal PA not covering any of the native pulmonary leaﬂets. No
signs for thoracic bleeding or stent-associated obstruction were
observed.
DISCUSSION
Congenital heart disease (CHD) affects almost 1% of all new-
borns [16] and represents a major cause for spontaneous abor-
tion and stillbirth [17]. Fetal cardiac intervention has thus
emerged as a novel treatment concept for a selected group of
patients with CHD [1,5]. In particular, balloon valvuloplasty of
heart valves has been established as a routine clinical procedure
in several centers worldwide. The patients of these interventions
mainly include either fetuses with high-grade aortic stenosis
with evolving hypoplastic left-heart syndrome (HLHS) or patients
with pulmonary atresia with evolving hypoplastic right-heart syn-
drome (HRHS) (reviewed by McElhinney et al. [1]). The prenatal
correction of these congenital cardiac defects, as a deﬁnite surgi-
cal repair at the earliest time point, could be associated with
several therapeutic advantages, including prevention of fetal
demise in selected cases [1,5], prevention of intrauterine cardiac
maldevelopment and reduction of severity of postnatal disease
[1], enhanced (scarless) healing reactions in early-gestational
fetuses [18], capacity for myocyte proliferation [19] as well as a
high regenerative capacity [20] in fetuses promoted by high
blood levels of progenitor cells [21]. Although ﬁrst clinical experi-
ences of fetal heart-valve intervention, including balloon valvulo-
plasty, seem highly promising [1,5], restenoses of the obstructed
segments have been repeatedly reported after prenatal cardiac-
balloon interventions [4,14].
The orthotopic fetal implantation of stented heart valves with
growth-adaptive capacities could combine an optimal and sus-
tained dilation of the stenotic regions and full restoration of
valvular functionality with the advantages of a catheter-based
minimally invasive implantation approach. The presented study
demonstrates for the ﬁrst time the principal technical feasibility
and acute safety of a fetal stent implantation into the PA via a
catheter-based trans-apical hybrid technique in the ovine fetal
model.
Recent experimental as well as pioneering clinical attempts
have focused primarily on percutaneous and/or transuterine
interventional approaches for treating severe aortic and pulmon-
ary stenoses [1–13]. While several experimental studies have also
addressed the feasibility of using fetal cardiac bypass [22,23],
open-fetal-cardiac surgery for valvotomy has not yet been suc-
cessfully achieved. Although allowing for a deﬁnite repair of the
structural defect, fetal loss following fetal open-heart interven-
tions has been reported [1].
In 2008, Schmidt et al. [24] already demonstrated the feasibil-
ity of percutaneous ultrasound-guided cardiac stenting of the
atrial septum in the ovine fetal model. Although they claimed
the principal feasibility of this percutaneous stent delivery in
utero, they observed severe complications by laceration of adja-
cent fetal organs. While they experienced unsuccessful implant-
ation via the transhepatic route, they also reported major
Figure 3: A three-dimensional CT reconstruction of the fetal heart veriﬁes the position of the self-expanding nitinol stent in the distal pulmonary artery (A). The
delivery system was advanced through the right ventricle (B, *) to the landing zone and the stent was deployed supravalvular distal to the pulmonary valve
annulus (arrow, B). The ventricular insertion site was closed using a pledged purse-string suture (B, ‡).
Figure 4: Post-mortem analysis conﬁrmed the stent position in the pulmon-
ary artery (A, line: proximal end; arrow: distal end) 2 cm distal from the
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laceration of the inferior vena cava via the transpulmonary route.
Given their optimal device diameters of <4 French,
percutaneous-valve-implantation attempts, by requiring signiﬁ-
cantly larger devices (present study: 14 French), would certainly
result in even more extensive fetal complications when using
these routes. Although aiming at the lowest perioperative
trauma, possible fetal-heart-valve implantations will have to
strike the balance between large device diameters and minimally
invasive delivery routes.
Also with regard to minimizing the perioperative trauma for
the fetus and the mother, several previous experimental studies
in the ovine model on fetal cardiac catheterization have mainly
focused on the establishment of noninvasive catheterization
techniques [2,3,8,9]. Kohl et al. [2] ﬁrst assessed a fetoscopic and
open transumbilical cardiac-catheterization procedure. Although
their indirect approach was minimally invasive, fetal bleeding at
the time of sheath removal or dislodgment was described as a
serious complication. Also in further investigations in the same
model assessing a fetoscopic direct cardiac access, bleeding oc-
curred and the acute loss of fetuses during the procedure could
not be prevented [9]. In a further ovine experimental study by
Jouannic et al. [3], a fetal transhepatic ultrasound-guided cardiac
catheterization was investigated as a potential alternative route
for fetal cardiac intervention. In this indirect, closed approach,
again several fetuses were lost due to acute bleeding complica-
tions. When using the ultrasound-guided cardiac puncture and
balloon dilation in human fetuses with anatomic cardiac obstruc-
tions, also several complications including pericardial tampon-
ade, hematothorax or even fetal death have been reported
[1,5,7,25]. In addition, in some cases, repeated punctures of the
heart were necessary to optimize positioning of interventional
devices [4], which further increased the risk for complications.
Although having the limitation of a uterine incision, no
major extracardiac complications occurred in the presented
study using a hybrid intervention. Only – as previously reported
[4,5] – perioperative bleeding during the insertion and removal of
the delivery device occurred and was substantial in one animal.
Even if these hemorrhagic complications can partly be attributed
to the prototypic design of the implantation device, bleeding at
the insertion site certainly displays also a major hurdle for future
prenatal trans-apical-valve implantations. These bleeding
complications, however, could clearly be reduced because of the
experience gained in the ﬁrst animal, suggesting a steep proced-
ural learning curve, as reported by previous studies [7,14]. The
long-term fate of the bleeding complications will have to be
addressed in longer follow-up investigations. In the end, it
seemed that acute hemorrhagic complications could eventually
be fully avoided when using a more technically mature device for
trans-apical fetal implantations.
A further procedural complication observed in the presented
interventions was the suboptimal positioning of one of the stents
(F1) in the PA. According to the steep learning curve reported
above, the other stents could be deployed within the landing
zone. Besides the difﬁculty of the beating-heart approach and
the diminutive dimensions of the fetal heart, the exact position-
ing was further challenged by the narrow landing zone, allowing
for only 2 mm proximal and distal tolerance.
The presented study demonstrates the principal technical
feasibility and acute safety of a fetal-stent implantation via a
catheter-based technique using the trans-apical route. Even if
percutaneous or fetoscopic trans-apical cardiac approaches
would be desirable, they lack control of direct fetal cardiac hem-
orrhage – a major issue in fetal cardiac catheterization. The pre-
sented transuterine open-chest closed-heart hybrid technique
represents a possible alternative for future approaches on the
route to prenatal heart-valve repair, also allowing for the inser-
tion of large devices, such as heart-valve delivery systems.
Further long-term studies are necessary to evaluate fetal
myocardial tolerance and long-term survival of the presented
technique before it may be applied to the clinical setting.
Figure 5: The stent (A and B, arrows) was deployed into the pulmonary artery (C and D, *). After delivery adequate perfusion of the ductus arteriosus Botalli (B, *)
as well as the pulmonary arteries (B, ‡) was observed using contrast angiography (A and B).
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